Trials / Conditions / Stargardt Macular Dystrophy
Stargardt Macular Dystrophy
6 registered clinical trials studyying Stargardt Macular Dystrophy — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults NCT07425574 | Astellas Pharma Global Development, Inc. | — |
| Recruiting | Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherit NCT07502664 | Ray Therapeutics, Inc. | — |
| Recruiting | A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Prelimina NCT06942572 | Splice Bio | Phase 1 / Phase 2 |
| Recruiting | Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retin NCT06375239 | Ray Therapeutics, Inc. | — |
| Active Not Recruiting | Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) NCT04239625 | Alkeus Pharmaceuticals, Inc. | Phase 2 |
| Enrolling By Invitation | Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease NCT02402660 | Alkeus Pharmaceuticals, Inc. | Phase 2 |